COST AND PRICE OF COMPARABLE BRANDED AND GENERIC PHARMACEUTICALS

被引：28
|
作者：
BLOOM, BS [1 ]
WIERZ, DJ [1 ]
PAULY, MV [1 ]
机构：
[1] PENN BLUE SHIELD,CAMP HILL,PA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1986年 / 256卷 / 18期
关键词：
D O I：
10.1001/jama.256.18.2523
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2523 / 2530
页数：8
相关论文
共 50 条
  • [41] Preliminary injunctions in generic and branded patent litigation
    Cohen, Simon
    England, Paul
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2013, 23 (09) : 1083 - 1086
  • [42] Branded versus generic clozapine for treatment of schizophrenia
    Makela, EH
    Cutlip, WD
    Stevenson, JM
    Weimer, JM
    Abdallah, ES
    Akhtar, RS
    Aboraya, AS
    Gunel, E
    [J]. ANNALS OF PHARMACOTHERAPY, 2003, 37 (03) : 350 - 353
  • [43] Chemicals in Preservative Free Tears, Branded and Generic
    Gao, Mary
    Wang, Margaret
    Wu, Gloria
    Bautista, Bonnibel
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [44] Candeblo® (plus) - Branded Drugs at Generic Prices
    不详
    [J]. JOURNAL FUR HYPERTONIE, 2019, 23 (02): : 62 - 62
  • [45] Generic Anticancer Drugs of the Jan Aushadhi Scheme in India and Their Branded Counterparts: The First Cost Comparison Study
    George, Thomas
    Baliga, Manjeshwar S.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [46] Therapeutic value and price of the new pharmaceuticals commercialized in Argentina: Are they worth what they cost?
    Canas, Martin
    Omar Buschiazzo, Hector
    Alejandro Urtasun, Martin
    [J]. SALUD COLECTIVA, 2019, 15
  • [47] Simultaneous improvement in development time, cost and quality: a practical framework for generic pharmaceuticals industry
    Chaudhuri, Atanu
    [J]. R & D MANAGEMENT, 2013, 43 (03) : 227 - 241
  • [48] Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules
    Gonzalez, Jorge
    Sismeiro, Catarina
    Dutta, Shantanu
    Stern, Philip
    [J]. INTERNATIONAL JOURNAL OF RESEARCH IN MARKETING, 2008, 25 (04) : 247 - 260
  • [49] Generic entry and the pricing of pharmaceuticals
    Frank, RG
    Salkever, DS
    [J]. JOURNAL OF ECONOMICS & MANAGEMENT STRATEGY, 1997, 6 (01) : 75 - 90
  • [50] COST-UTILITY ANALYSIS OF ARIPIPRAZOLE, OLANZAPINE BRANDED GENERIC, AND OLANZAPINE GENERIC ON STABLE PHASE OF SCHIZOPHRENIA PATIENT AT MENTAL HEALTH HOSPITAL IN JAKARTA
    Anggriani, Y.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S53 - S54
12345